Identification of hub genes associated with cognition in the hippocampus of Alzheimer’s Disease

References

• Eratne D, Loi SM, Farrand S, et al. Alzheimer’s disease: clinical update on epidemiology, pathophysiology and diagnosis. Australas Psychiatry. 2018 Aug;26(4):347–357.
   PubMed Web of Science ®Google Scholar
• Lane CA, Hardy J, Schott JM. Alzheimer’s disease. Eur J Neurol. 2018Jan01;25(1):59–70. Blackwell Publishing Ltd.
   PubMed Web of Science ®Google Scholar
• Zanetti O, Solerte SB, Cantoni F. Life expectancy in Alzheimer’s disease (AD). Arch Gerontol Geriatr. 2009;49(Suppl 1):237–243.
   PubMed Web of Science ®Google Scholar
• Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med. 2016 Jun;8(6):595–608.
   PubMed Web of Science ®Google Scholar
• Bliss TVP, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 1993;361(6407):31–39.
   PubMed Web of Science ®Google Scholar
• Berchtold NC, Cribbs DH, Coleman PD, et al. Gene expression changes in the course of normal brain aging are sexually dimorphic. Proc Natl Acad Sci U S A. 2008 Oct;105(40):15605–15610.
   PubMed Web of Science ®Google Scholar
• Kumon H, Yoshino Y, Funahashi Y, et al. PicalM mRNA expression in the blood of patients with neurodegenerative diseases and geriatric depression. J Alzheimer’s Dis. 2021;79(3):1055–1062.
   PubMed Web of Science ®Google Scholar
• Xu H, Jia J. Immune-related hub genes and the competitive endogenous RNA network in Alzheimer’s disease. J Alzheimer’s Dis. 2020;77(3):1255–1265.
   Web of Science ®Google Scholar
• Quan X, Liang H, Chen Y, et al. Related network and differential expression analyses identify nuclear genes and pathways in the hippocampus of Alzheimer disease. Med Sci Monit. 2020;26. DOI:10.12659/MSM.919311.
   Web of Science ®Google Scholar
• Yan T, Ding F, Zhao Y. Integrated identification of key genes and pathways in Alzheimer’s disease via comprehensive bioinformatical analyses. Hereditas. 2019;156(1). DOI:10.1186/s41065-019-0101-0
   Google Scholar
• Xu M, Liu Y, Huang Y, et al. Re-exploring the core genes and modules in the human frontal cortex during chronological aging: insights from network-based analysis of transcriptomic studies. Aging (Albany NY). 2018;10(10):2816–2831.
   Google Scholar
• Ling J, Yang S, Huang Y, et al. Identifying key genes, pathways and screening therapeutic agents for manganese-induced Alzheimer disease using bioinformatics analysis. Med (United States). 2018. DOI:10.1097/MD.0000000000010775
   Google Scholar
• R Core Team. R: a language and environment for statistical computing. In: R Foundation for Statistical Computing. Vienna, Austria. URL http://www.R-project.org/. 2019.
   Google Scholar
• Gautier L, Cope L, Bolstad BM, et al. Affy - analysis of affymetrix GeneChip data at the probe level. Bioinformatics. 2004;20(3):307–315.
   PubMed Web of Science ®Google Scholar
• Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4(2):249–264.
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015 Apr;43(7):e47–e47.
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, et al. ClusterProfiler: an R package for comparing biological themes among gene clusters. Omi A J Integr Biol. 2012 May;16(5):284–287.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45(D1):D362–D368.
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003 Nov;13(11):2498–2504.
   PubMed Web of Science ®Google Scholar
• Lin CY, Chin CH, Wu HH, et al. Hubba: hub objects analyzer–a framework of interactome hubs identification for network biology. Nucleic Acids Res. 2008 July, 36(suppl_2):W438–W443.
   Google Scholar
• Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1(2):848–858.
   PubMed Web of Science ®Google Scholar
• César KG, Brucki S, Takada L T, et al. Prevalence of cognitive impairment without dementia and dementia in Tremembé, Brazil. Alzheimer Dis Assoc Disord. 2016;30(3):264–271.
   Web of Science ®Google Scholar
• Hale JM, Schneider DC, Mehta NK, et al. Cognitive impairment in the U.S.: lifetime risk, age at onset, and years impaired. SSM Popul Heal. 2020;11:100577.
   Web of Science ®Google Scholar
• Qiu C, Fratiglioni L, Perry G. Aging without dementia is achievable: current evidence from epidemiological research. J Alzheimers Dis. 2018;62(3):933–942.
   Web of Science ®Google Scholar
• Pannuzzo M. Beta-amyloid pore linked to controlled calcium influx into the cell: a new paradigm for Alzheimer’s Disease. Alzheimer’s Dement. 2021. DOI:10.1002/alz.12373
   PubMed Web of Science ®Google Scholar
• Jeong Y, Cho HY, Kim M, et al. Synaptic plasticity-dependent competition rule influences memory formation. Nat Commun. 2021. DOI:10.1038/s41467-021-24269-4.
   Web of Science ®Google Scholar
• Rajmohan R, Reddy PH. Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer’s disease neurons. J Alzheimers Dis. 2017. DOI:10.3233/JAD-160612
   PubMed Web of Science ®Google Scholar
• Scheff SW, Price DA, Schmitt FA, et al. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology. 2007;68(18):1501–1508.
   PubMed Web of Science ®Google Scholar
• Scheff SW, Ansari MA, Mufson EJ. Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer’s disease pathology. Neurobiol Aging. 2016;42:1–12.
   PubMed Web of Science ®Google Scholar
• Moreno-Jiménez EP, Flor-García M, Terreros-Roncal J, et al. Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer’s disease. Nat Med. 2019Apr01;25(4):554–560. Nature Publishing Group.
   PubMed Web of Science ®Google Scholar
• Petrella C, Di Certo MG, Barbato C, et al. Neuropeptides in Alzheimer’s Disease: an Update. Curr Alzheimer Res. 2019 Aug;16(6):544–558.
   PubMed Web of Science ®Google Scholar
• Kandimalla R, Reddy PH. Therapeutics of neurotransmitters in Alzheimer’s disease. J Alzheimers Dis. 2017;57(4):1049–1069. IOS Press.
   PubMed Web of Science ®Google Scholar
• Pfeiffer P, Egorov AV, Lorenz F, et al. Clusters of cooperative ion channels enable a membrane-potential-based mechanism for short-term memory. Elife. 2020 Feb;9: DOI:10.7554/eLife.49974
   PubMed Web of Science ®Google Scholar
• Raiteri M, Paudice P, Vallebuona F. Release of cholecystokinin in the central nervous system. Neurochem Int. 1993 Jun;22(6):519–527.
   PubMed Web of Science ®Google Scholar
• Plagman A, Hoscheidt S, McLimans KE, et al. Cholecystokinin and Alzheimer’s disease: a biomarker of metabolic function, neural integrity, and cognitive performance. Neurobiol Aging. 2019Apr;76:201–207.
   PubMed Web of Science ®Google Scholar
• Lo CM, Samuelson LC, Chambers JB, et al. Characterization of mice lacking the gene for cholecystokinin. Am J Physiol - Regul Integr Comp Physiol. 2008;294(3):R803–R810.
   PubMed Web of Science ®Google Scholar
• Ceccarini J, Casteels C, Ahmad R, et al. Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson’s disease. Eur J Nucl Med Mol Imaging. 2019;46(11):2348–2357.
   PubMed Web of Science ®Google Scholar
• Aso E, Andrés-Benito P, Ferrer I. Genetic deletion of CB1 cannabinoid receptors exacerbates the Alzheimer-like symptoms in a transgenic animal model. Biochem Pharmacol. 2018;157:210–216.
   PubMed Web of Science ®Google Scholar
• Crunfli F, Vrechi TA, Costa AP, et al. Cannabinoid receptor type 1 agonist ACEA improves cognitive deficit on STZ-induced neurotoxicity through apoptosis pathway and NO modulation. Neurotox Res. 2019;35(3):516–529.
   PubMed Web of Science ®Google Scholar
• Li J-T, Xie X-M, Yu J-Y, et al. Suppressed calbindin levels in hippocampal excitatory neurons mediate stress-induced memory loss. Cell Reports. 2017;21(4):891–900.
   PubMed Web of Science ®Google Scholar
• You JC, Muralidharan K, Park JW, et al. Epigenetic suppression of hippocampal calbindin-D28k by ΔfosB drives seizure-related cognitive deficits. Nat Med. 2017 Nov;23(11):1377–1383.
   PubMed Web of Science ®Google Scholar
• Verdaguer E, Brox S, Petrov D, et al. Vulnerability of calbindin, calretinin and parvalbumin in a transgenic/knock-in APPswe/PS1dE9 mouse model of Alzheimer disease together with disruption of hippocampal neurogenesis. Exp Gerontol. 2015;69:176–188.
   PubMed Web of Science ®Google Scholar
• Rösler N, Wichart I, Jellinger KA. Ex vivo lumbar and post mortem ventricular cerebrospinal fluid substance P-immunoreactivity in Alzheimer’s disease patients. Neurosci Lett. 2001;299(1–2):117–120.
   PubMed Web of Science ®Google Scholar
• Johansson P, Almqvist EG, Wallin A, et al. Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer’s disease. Neurosci Lett. 2015Nov;609:58–62.
   PubMed Web of Science ®Google Scholar
• Perry EK, Oakley AE, Candy JM, et al. Properties and possible significance of substance P and insulin fibrils. Neurosci Lett. 1981 Sep;25(3):321–325.
   PubMed Web of Science ®Google Scholar
• Campolongo P, Ratano P, Ciotti MT, et al. Systemic administration of substance P recovers beta amyloid-induced cognitive deficits in rat: involvement of Kv potassium channels. Plos One. 2013;8(11):e78036.
   PubMed Web of Science ®Google Scholar
• Fernandes J, Mudgal J, Rao CM, et al. N-acetyl-L-tryptophan, a substance-P receptor antagonist attenuates aluminum-induced spatial memory deficit in rats. Toxicol Mech Methods. 2018 Jun;28(5):328–334.
   PubMed Web of Science ®Google Scholar
• Armstrong C, Soltesz I. Basket cell dichotomy in microcircuit function. J Physiol. 2012;590(4):683–694.
   PubMed Web of Science ®Google Scholar
• Lupica CR, Hu Y, Devinsky O, et al. Cannabinoids as hippocampal network administrators. Neuropharmacology. 2017;124:25–37.
   PubMed Web of Science ®Google Scholar
• Lupica CR, Hoffman AF. Cannabinoid disruption of learning mechanisms involved in reward processing. Learn Mem. 2018;25(9):435–445.
   PubMed Web of Science ®Google Scholar
• Whissell PD, Bang JY, Khan I, et al. Selective activation of cholecystokinin-expressing GABA (CCK-GABA) neurons enhances memory and cognition. eneuro. 2019;6(1):ENEURO.0360–18.
   PubMed Web of Science ®Google Scholar
• Del Pino I, Brotons-Mas JR, Marques-Smith A, et al. Abnormal wiring of CCK+ basket cells disrupts spatial information coding. Nat Neurosci. 2017;20(6):784–792.
   PubMed Web of Science ®Google Scholar
• Zhang B, Chen X, Lin Y, et al. Impairment of synaptic plasticity in hippocampus is exacerbated by methylprednisolone in a rat model of traumatic brain injury. Brain Research. 2011;1382:165–172.
   PubMed Web of Science ®Google Scholar
• Harris KD, Hochgerner H, Skene NG, et al. Classes and continua of hippocampal CA1 inhibitory neurons revealed by single-cell transcriptomics. Plos Biol. 2018;16(6):e2006387.
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhao M, Han Y, et al. GABAergic inhibitory interneuron deficits in alzheimer’s disease: implications for treatment. Front Neurosci. 2020. DOI:10.3389/fnins.2020.00660
   Web of Science ®Google Scholar
• Abbas G, Mahmood W, Kabir N. Recent progress on the role of GABAergic neurotransmission in the pathogenesis of Alzheimer’s disease. Rev Neurosci. 2016;27(4):449–455.
   PubMed Web of Science ®Google Scholar